Media coverage
1
Media coverage
Title Aeglea BioTherapeutics to Release Updated Phase 1/2 Data for Pegzilarginase in Patients with Arginase 1 Deficiency in an Oral Presentation at the 2019 Annual Meeting of the Society for Inherited Metabolic Disorders Media name/outlet Wireless News(Close-up Media) Country/Territory United States Date 4/04/19 Persons George Diaz